Childhood fracture disease
Conditions
Interventions
Rimazolen benzenesulfonate group (R group):Rimazolen Besylate 1.5 mg/kg Nasal Drops
Dexmedetomidine group (D group):Dexmedetomidine 2 µ g/kg nasal drops
Sponsors
The Second Affiliated Hospital of Inner Mongolia Medical University
Eligibility
Sex/Gender
All
Age
1 Years to 6 Years
Inclusion criteria
Inclusion criteria: Children with upper or lower limb fractures who are scheduled for surgical treatment; Age: 1-6 years old; ASA classification: I~II.
Exclusion criteria
Exclusion criteria: Abnormal or malformed nasal cavity; Allergic to remifentanil besylate or dexmedetomidine; Upper respiratory tract infection in the past two weeks; Asthma; Heart conduction block; Individuals with contraindications to sedation or anesthesia No informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improved alertness/sedation score;Sedation onset time;Number of cases of remedial sedation;Sedation duration; | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction of the surgeon and family members with the sedation of the patient;adverse reaction; | — |
Countries
China
Contacts
Public ContactLi Yating
The Second Affiliated Hospital of Inner Mongolia Medical University
Outcome results
None listed